Evaluation of the effects of an artificial intelligence system on endoscopy quality and preliminary testing of its performance in detecting early gastric cancer: a randomized controlled trial

Abstract

Background and study aims: Qualified esophagogastroduodenoscopy (EGD) is a prerequisite for detecting upper gastrointestinal lesions especially early gastric cancer (EGC). Our previous report showed that artificial intelligence system could monitor blind spots during EGD. Here, we updated the system to a new one (named ENDOANGEL), verified its effectiveness on improving endoscopy quality and pre-tested its performance on detecting EGC in a multi-center randomized controlled trial. Patients and methods: ENDOANGEL was developed using deep convolutional neural networks and deep reinforcement learning. Patients undergoing EGD examination in 5 hospitals were randomly assigned to ENDOANGEL-assisted (EA) group or normal control (NC) group. The primary outcome was the number of blind spots. The second outcome includes performance of ENDOANGEL on predicting EGC in clinical setting. Results: 1,050 patients were recruited and randomized. 498 and 504 patients in EA and NC groups were respectively analyzed. Compared with NC, the number of blind spots was less (5.382±4.315 vs. 9.821±4.978, p<0.001) and the inspection time was prolonged (5.400±3.821 min vs. 4.379±3.907 min, p<0.001) in EA group. In the 498 patients from EA group, 196 gastric lesions with pathological results were identified. ENDOANGEL correctly predicted all 3 EGC (1 mucosal carcinoma and 2 high-grade neoplasia) and 2 advanced gastric cancer, with a per-lesion accuracy of 84.69%, sensitivity of 100% and specificity of 84.29% for detecting GC. Conclusions: The results of the multi-center study confirmed that ENDOANGEL is an effective and robust system to improve the quality of EGD and has the potential to detect EGC in real time.

An artificial intelligence system for distinguishing between gastrointestinal stromal tumors and leiomyomas using endoscopic ultrasonography

“…Artificial intelligence (AI), especially deep learning, has already shown powerful abilities in medical imaging recognition [9][10][11][12][13][14][15]. AI can automatically identify quantitative pixel-level features [16,17].…”

Applications of Artificial Intelligence for the Diagnosis of Gastrointestinal Diseases

“…Therefore, Tang et al [ 43 ] developed and validated a real-time DL-CNN system for detecting EGC that confirmed high accuracy rates of AI with sensitivity, specificity, and the AUC ranging from 85.9% to 95.5%, 81.7–90.3%, and 0.887–0.940, respectively. Finally, Wu et al [ 44 ] carried out a multicenter, randomized, controlled trial using a deep-learning CNN and deep reinforcement-learning system named “ENDOANGEL”. Patients included in the ENDOANGEL group had significantly fewer blind spots compared with the control group (mean 5.38 (standard deviation (SD) 4.32) vs. 9.82 (SD 4.98); p < 0.001) and longer inspection time (5.40 (SD 3.82) vs. 4.38 (SD 3.91) minutes; p < 0.001).…”

Machine Learning for Future Subtyping of the Tumor Microenvironment of Gastro-Esophageal Adenocarcinomas

“…Several studies trained CNNs to aid early detection in GEA, recently summarized in a meta-analysis that found superiority of applying DL for detection of Barrett's esophagus [132][133][134][135][136][137]. Currently, clinical trials are already investigating its sensitivity and specificity, if applied in a clinical setting, with several studies showing DL models to identify early GEA [138,139]. In detail, 3D endoscopy imaging techniques, in combination with DL, may be applied to quantify the depth of Barrett's esophagus [140].…”